Project Grant R01EB036730
- Federal Project Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded Massachusetts General Hospital a $269,460 Project Grant effective August 1, 2025 through July 31, 2027 under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award supports the development of advanced magnetic resonance imaging (MRI) acquisition and analysis methods that combine diffusion-relaxometry...
- Federal Grant Award Summary Boston Children's Hospital received a $996,466 Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective August 1, 2025 through May 31, 2029. The award supports the development and validation of motion- and distortion-robust quantitative magnetic resonance imaging (QMRI) technology designed to enhance...
- Federal Project Grant Award Summary The Johns Hopkins University received a $422,623 Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), awarded August 1, 2025, with a completion date of June 30, 2029. This research initiative focuses on developing high-fidelity brain perfusion magnetic resonance imaging (MRI) techniques specifically...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded The Johns Hopkins University a $682,299 Project Grant effective August 1, 2025, through July 31, 2029, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The research project, titled "Ultrafast Optical Brain Imaging via Blurred Matrix Completion," focuses on developing an advanced computational imaging approach...
- This $1,336,000 Project Grant awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the CFDA 93.286 "Discovery and Applied Research for Technological Innovations to Improve Human Health" program supports the development of a rapid, motion-robust, and low-gadolinium MRI technology for pediatric brain tumors. The key objectives are to (1) develop cutting-edge technologies for rapid, motion-robust, and quantitative MRI scans to reduce sedation needs...
- The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded the University of Wisconsin–Madison a $611,597 Project Grant effective June 1, 2026, through February 28, 2030, under CFDA 93.286 (Discovery and Applied Research for Technological Innovations to Improve Human Health). The award supports the development and validation of next-generation, confounder-corrected Magnetic Resonance Imaging (MRI)-based Intra-Voxel Incoherent Motion (IVIM) methods for simultaneous...
- Project Grant Summary Boston Children's Hospital received a $1,155,809 project grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), effective September 1, 2025, through May 31, 2030. The award supports the development of motion-robust quantitative magnetic resonance imaging (MRI) techniques for measuring iron levels in newborn brains, with particular focus on preterm infants who...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Johns Hopkins University a Project Grant of $443,931 under the Mental Health Research Grants program (CFDA 93.242) for the period July 1, 2025 through June 30, 2027. This research project aims to develop and validate novel methodologies for accurately tracking structural brain changes using low-field (0.05T) magnetic resonance imaging (MRI) technology coupled with autonomous control systems and...
- Federal Project Grant Award Summary New York University School of Medicine received a $114,562 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective June 1, 2026, through May 31, 2028. This K99 award supports the development and validation of a novel diffusion-weighted magnetic resonance imaging (DWI) framework designed to...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded The Johns Hopkins University a $428,152 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) for the period September 1, 2025 through August 31, 2027. The award supports development and validation of diffusion-model-enabled computational observers designed to evaluate the clinical diagnostic task performance of...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded the University of Maryland, Baltimore a $516,628 Project Grant on June 1, 2026, under CFDA 93.286 (Discovery and Applied Research for Technological Innovations to Improve Human Health) to develop real-time motion correction techniques for single-shot diffusion-weighted magnetic resonance imaging (DWI) of the brain. The project will deliver a suite of acquisition-based solutions, including two novel magnetic resonance-based navigators and improved reconstruction algorithms for raw DWI data, designed to eliminate signal errors and dropouts induced by head motion during brain imaging acquisitions. These technologies aim to improve image quality for clinical applications (such as acute stroke assessment) and large-scale research initiatives including the Adolescent Brain Cognitive Development Study, Healthy Brain Child Development Study, Alzheimer's Disease Neuroimaging Initiative, and Human Connectome Project. The deliverables will be validated through quantitative metrics testing in 25 healthy adults and 50 hospitalized infants, with particular focus on addressing motion artifacts in vulnerable populations including confused or agitated patients and infants unable to remain still during extended imaging sessions. The project extends through March 31, 2030, and addresses a significant clinical need by implementing motion correction "at the source" within individual acquisitions rather than relying solely on post-processing approaches, thereby improving downstream DWI processing and analysis for brain microstructure assessment.Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $516.6k | 5/27/26 |